171 related articles for article (PubMed ID: 33175305)
1. Inflammatory breast cancer associated with amyopathic dermatomyositis: a case report.
Inaguma G; Shimada A; Tsunoda J; Matsuzaki T; Nishi T; Seki H; Matsumoto H
Surg Case Rep; 2020 Nov; 6(1):284. PubMed ID: 33175305
[TBL] [Abstract][Full Text] [Related]
2. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
3. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice.
Lee SB; Yu JH; Park H; Kim HJ; Park SH; Chae BJ; Youn HJ; Jung SY; Kim EK; Jung YS; Son BH
Asian J Surg; 2019 Jan; 42(1):314-319. PubMed ID: 30049563
[TBL] [Abstract][Full Text] [Related]
4. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
[TBL] [Abstract][Full Text] [Related]
5. Skin metastasis of breast cancer clinically undistinguished from amyopathic dermatomyositis.
Seishima M; Shimizu H; Oyama Z
Eur J Dermatol; 2001; 11(2):131-3. PubMed ID: 11275811
[TBL] [Abstract][Full Text] [Related]
6. Targeted axillary dissection and sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy - a retrospective study.
Coufal O; Zapletal O; Gabrielová L; Fabian P; Schneiderová M
Rozhl Chir; 2018; 97(12):551-557. PubMed ID: 30646734
[TBL] [Abstract][Full Text] [Related]
7. Triple-Negative Breast Cancer with Dermatomyositis: A Case Report and Literature Review.
Chen X; Chen A; Liu C; Zhang B
Cancer Manag Res; 2022; 14():569-576. PubMed ID: 35210854
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer.
Brady EW
Breast J; 2002; 8(2):97-100. PubMed ID: 11896755
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Breast Cancer Associated with Dermatitis That Was Difficult to Differentiate from Dermatomyositis].
Goto W; Kashiwagi S; Asano Y; Takada K; Morisaki T; Noda S; Takashima T; Onoda N; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1930-1932. PubMed ID: 29394824
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Recurrent Breast Cancer with Contralateral Axillary Node Recurrence Cured after Mastectomy for Ipsilateral Breast Tumor Recurrence].
Nakakuma T; Takahashi K; Ueno S; Tabei T; Inada T; Kondou Y; Kosaka Y; Sengoku N
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2018-2020. PubMed ID: 32157045
[TBL] [Abstract][Full Text] [Related]
11. A mild form of dermatomyositis as a prodromal sign of lung adenocarcinoma: a case report.
Papakonstantinou E; Kapp A; Raap U
J Med Case Rep; 2016 Feb; 10():34. PubMed ID: 26851947
[TBL] [Abstract][Full Text] [Related]
12. Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
Dalus K; Reitsamer R; Holzmannhofer J; Rendl G; Pirich C; Kronberger C; Rettenbacher L
Nuklearmedizin; 2011; 50(1):33-8. PubMed ID: 21336417
[TBL] [Abstract][Full Text] [Related]
13. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
[TBL] [Abstract][Full Text] [Related]
14. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
16. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
[TBL] [Abstract][Full Text] [Related]
17. [Feasibility of sentinel lymph node biopsy peri-neoadjuvant chemotherapy in breast cancer].
Zhao J; Song ZW; Huang Y; Hao XP; Liang F; Wang SB; Jin SJ; Yu CZ
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2538-41. PubMed ID: 23158793
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.
van Rijk MC; Nieweg OE; Rutgers EJ; Oldenburg HS; Olmos RV; Hoefnagel CA; Kroon BB
Ann Surg Oncol; 2006 Apr; 13(4):475-9. PubMed ID: 16485148
[TBL] [Abstract][Full Text] [Related]
19. A case report of locally advanced triple negative breast cancer showing pathological complete response to weekly paclitaxel with bevacizumab treatment following disease progression during anthracycline-based neoadjuvant chemotherapy.
Shigematsu H; Ozaki S; Yasui D; Hirata T
Int J Surg Case Rep; 2017; 39():293-296. PubMed ID: 28888915
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of pregnancy associated breast cancer].
Székely B; Langmár Z; Somlai K; Szentmártoni G; Szalay K; Korompay A; Szász AM; Kulka J; Bánhidy F; Dank M
Orv Hetil; 2010 Aug; 151(32):1299-303. PubMed ID: 20656670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
